Results 11 to 20 of about 53,707 (310)

Conjugate vaccines [PDF]

Archives of Disease in Childhood, 2005
A, Finn, P, Heath
openaire   +3 more sources

A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults. [PDF]

, 2010
BACKGROUND: Streptococcus pneumoniae is a leading and serious coinfection in adults with human immunodeficiency virus (HIV) infection, particularly in Africa.
Zijlstra, EE, Molyneux, Malcolm E, White, Sarah A., Mwaiponya, Martin, Mwalukomo, Thandie, Gordon, Stephen, Zijlstra, Eduard E, Longwe, Herbert, French, N, Mwalukomo, T, White, SA, French, Neil, Gordon, SB, Mwaiponya, M, Gilks, CF, Gilks, Charles F, Mwafulirwa, Gershom, Molyneux, Malcolm E., Mwafulirwa, G, Molyneux, ME, Gordon, Stephen B., Gordon, Stephen B, White, Sarah; id_orcid, Longwe, H, Gilks, Charles F., White, Sarah A, Zijlstra, Eduard E.   +26 more
core   +1 more source

Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis. [PDF]

, 2012
OBJECTIVE: To estimate the cost effectiveness of vaccinating people with high risk conditions against invasive pneumococcal disease using the 13 valent pneumococcal conjugate vaccine.
Edmunds, W. John, van Hoek, Albert Jan, Trotter, Caroline L, Rozenbaum, Mark H., C. L. Trotter, Miller, Elizabeth, Rozenbaum, Mark H, D. Fleming, Trotter, Caroline L., E. Miller, M. H. Rozenbaum, Edmunds, W John, W. J. Edmunds, Fleming, Douglas, A. J. van Hoek   +14 more
core   +1 more source

Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013. [PDF]

, 2015
In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad.
Greenwood, Brian M, Ngadoua, C, Kadidja Gamougam, Dominique A. Caugant, Trotter, Caroline L, Toralta, J, Greenwood, B M, Ngadoua, Cyriaque, Fermon, Florence, Manigart, Olivier, Daugla, D M, Olivier Manigart, Daugla, Doumagoum M, Florence Fermon, Page, A-L, Caugant, D A, Djingarey, M H, Doumagoum M. Daugla, Fermon, F, James M. Stuart, Page, Anne-Laure, Trotter, C L, Caugant, Dominique A, Djingarey, Mamoudou H, Anne-Laure Page, Mamoudou Djingarey, Gamougam, Kadidja, Cyriaque Ngadoua, Toralta, Jacques, Stuart, J M, Stuart, James M, Gamougam, K, Manigart, O, Caroline L. Trotter, Jacques Toralta, Brian M. Greenwood   +35 more
core   +1 more source

Decrease in Pneumococcal Co-Colonization following Vaccination with the Seven-Valent Pneumococcal Conjugate Vaccine [PDF]

, 2012
Understanding the epidemiology of pneumococcal co-colonization is important for monitoring vaccine effectiveness and the occurrence of horizontal gene transfer between pneumococcal strains.
Sá-Leão, Raquel, Katherine Gould, Francisco Pinto (188116), Katherine Gould (188123), Hinds, Jason, Pinto, Francisco, Kathrin Mühlemann (109266), Jason Hinds (41307), Silvio D. Brugger, Raquel Sá-Leão (188130), Carina Valente, Kathrin Mühlemann, Gould, K, Valente, C, Brugger, Silvio D., Hermínia de Lencastre, Carina Valente (188109), de Lencastre, Hermínia, Raquel Sá-Leão, Silvio D Brugger, Valente, Carina, Hinds, J, Silvio D. Brugger (109258), Pinto, F, de Lencastre, H, Sá-Leão, R, Brugger, SD, Jason Hinds, Francisco Pinto, Mühlemann, K, Hermínia de Lencastre (1970), Gould, Katherine, Mühlemann, Kathrin   +32 more
core   +1 more source

Safety of Combination of a Tetravalent Meningococcal Conjugate Vaccine Against Serogroups A, C, Y, W-135 With Other Vaccine Preparations: a Prospective Study of a Series of Cases Among Healthy Children and Children With Various Health Abnormalities

Вопросы современной педиатрии, 2017
Meningococcal infection is an acute disease caused by Neisseria meningitidis, which proceeds with a diverse clinical aspect from nasopharyngitis to meningococcal meningitis and meningococcemia.
Leyla S. Namazova-Baranova, Daria A. Novikova, Marina V. Fedoseenko, Anna G. Gaivoronskaya, Natalia E. Tkachenko, Tatiana A. Kaljuzhnaya, Firuza Ch. Shakhtakhtinskaya, Marika I. Broeva   +7 more
doaj   +1 more source

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease. [PDF]

, 2010
BACKGROUND: The 7-valent pneumococcal conjugate vaccine has been introduced in national immunisation programmes of most industrialised countries and recently in two African GAVI eligible countries (Rwanda and The Gambia). However the long term effects of
George, Robert, Robert George, Y.H. Choi, Miller, Elizabeth, Edmunds, John W., Elizabeth Miller, Melegaro, Alessia, Yoon Hong Choi, E. Miller, Choi, Yoon Hong, Gay, Nigel J, Edmunds, W John, Nigel J Gay, R. George, W John Edmunds, Alessia Melegaro, N.J. Gay, W.J. Edmunds, Gay, Nigel J.   +18 more
core   +1 more source

Pneumococcal antibody concentrations and carriage of pneumococci more than 3 years after infant immunization with a pneumococcal conjugate vaccine. [PDF]

, 2012
BACKGROUND: A 9-valent pneumococcal conjugate vaccine (PCV-9), given in a 3-dose schedule, protected Gambian children against pneumococcal disease and reduced nasopharyngeal carriage of pneumococci of vaccine serotypes.
Greenwood, Brian M, Godwin C. Enwere, Brown J Okoko, Nsekpong, Ekpedeme D, Godwin C Enwere, Ekpedeme D Nsekpong, Syed M. A. Zaman, Aderonke A. Odutola, Saaka, Mark, Zaman, Syed MA, Akinsola, Adebayo K, Richard A. Adegbola, Syed M A Zaman, Adebayo K. Akinsola, Aderonke A Odutola, Richard A Adegbola, Martin O. C. Ota, Okoko, Brown J, Odutola, Aderonke A, Martin O C Ota, Cutts, Felicity T, Felicity T Cutts, Ekpedeme D. Nsekpong, Felicity T. Cutts, Adebayo K Akinsola, Brown J. Okoko, Enwere, Godwin C, Brian M Greenwood, Mark Saaka, Adegbola, Richard A, Brian M. Greenwood, Ota, Martin OC   +31 more
core   +1 more source

Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in low- and middle-income countries: regional analysis and assessment of major determinants. [PDF]

, 2013
OBJECTIVES: To estimate the cost-effectiveness of Haemophilus influenzae type b (Hib) conjugate vaccine in low- and middle-income countries and identify the model variables, which are most important for the result.
Clark, Andrew, Griffiths, Ulla Kou, Hajjeh, Rana   +2 more
core   +1 more source

Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands

BMC Infectious Diseases, 2012
Background The first meningococcal serogroup C (MenC) conjugate vaccine was licensed in 1999 and introduced in the United Kingdom. Countries that have implemented the MenC vaccine since then in their national immunisation programmes use different ...
Kaaijk Patricia, van der Ende Arie, Berbers Guy, van den Dobbelsteen Germie PJM, Rots Nynke Y   +4 more
doaj   +1 more source